Table 5.
Multiple models for PFS and OS based on TTC
| PFS | OS | |||
|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | |
| TTC a | ||||
| ≤ 33 | 1 (Reference) | 1 (Reference) | ||
| 34–40 | 1.18 (0.91–1.52) | 0.221 | 1.57 (1.10–2.23) | 0.012 |
| 41–49 | 1.18 (0.90–1.53) | 0.227 | 1.85 (1.31–2.62) | 0.001 |
| > 49 | 1.15 (0.87–1.51) | 0.338 | 1.51 (1.03–2.19) | 0.033 |
| TTC b | 1.003 (0.997–1.009) | 0.333 | 1.009 (1.002–1.017) | 0.011 |
| P for trendc | 0.381* | 0.031* | ||
Abbreviation: PFS, Progression-free survival; OS, Overall survival; TTC, Time to postoperative adjuvant chemotherapy after the completion of neoadjuvant chemotherapy; HR, Hazard ratio; CI, Confidence interval; *, P value for Ptrend
a Adjusted for age, type, grade, stage, upper abdominal surgery, bowel resection, lymphadenectomy, residual disease, postoperative complication, cycle of neoadjuvant chemotherapy and TTC (included as a quartile categorical variable)
b Adjusted for age, type, grade, stage, upper abdominal surgery, bowel resection, lymphadenectomy, residual disease, postoperative complication, cycle of neoadjuvant chemotherapy and TTC (included as a continuous variable)
c Adjusted for age, type, grade, stage, upper abdominal surgery, bowel resection, lymphadenectomy, residual disease, postoperative complication and cycle of neoadjuvant chemotherapy